BioFarma received support from the foundation to expand access to its novel oral poliovirus vaccine type 2 (nOPV2) for the Global Polio Eradication Initiative. Investment Date: April 2022
Program Areas: Global Development
Bill & Melinda Gates Foundation, Swedish International Development Cooperation Agency, and UNICEF Announce $150 Million Guarantee to Support Access to Vaccines and Health Supplies in Low- and Middle-Income Countries
SEATTLE – STOCKHOLM – COPENHAGEN (November 12, 2021) – The Bill & Melinda Gates Foundation, the Swedish International Development Cooperation Agency (Sida), and UNICEF today announced a $150 million financial guarantee to help UNICEF procure vaccines and other health-related supplies Read More
Bill & Melinda Gates Foundation Invests In 1MG
Gurugram-headquartered healthtech startup 1MG has now added yet another global investor to its cap table with fresh funds and offering intellectual property. According to the Ministry of Corporate Affairs filings accessed by Inc42, the company on Thursday (January 30) received an Read More
Alongside the UK’s Department for International Development, the foundation provided support to UNFPA Supplies to create a pool of flexible financing to improve reliable access to family planning commodities in low- and middle-income countries supported by UNFPA Supplies. Investment Date: Read More
Stellapps is focused on the development of integrated software and hardware tools that allow dairy processors to manage their supply chains. The primary use case of the Stellapps’ technologies is at milk collection centers where individual SHFs sell their milk. Read More
Pledge Guarantee for Health
The foundation provided support to the UN Foundation’s Pledge Guarantee for Health to improve procurement practices to avoid stockouts of family planning products in the developing world.
The foundation provided support to expand UNICEF’s Vaccine Independence Initiative. This program allows countries to bridge-finance the procurement of vaccines while they await budget funds to be available.
The foundation provided a volume guarantee to Novartis to reduce the price of oral polio virus vaccines in the developing world.
The foundation partnered with Sanofi to secure a reduced price for Inactivated Polio Vaccine (IPV).
Root Capital provides agricultural enterprises with the capital and training they need to unlock their potential and become engines of impact in rural communities.